Cargando…
EPHA5 mutations predict survival after immunotherapy in lung adenocarcinoma
Eph receptors constitute the largest family of RTKs, and their associations with antitumor immunity and immunotherapy are largely unknown. By integrating genomic, transcriptomic and clinical data from cohorts in public databases, we identified EPHA5 as the most common mutated gene of Eph receptors i...
Autores principales: | Chen, Zhiming, Chen, Ji, Ren, Dandan, Zhang, Jiao, Yang, Ying, Zhang, Henghui, Mao, Beibei, Ma, Haitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834994/ https://www.ncbi.nlm.nih.gov/pubmed/33288738 http://dx.doi.org/10.18632/aging.202169 |
Ejemplares similares
-
EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma
por: Bai, Hua, et al.
Publicado: (2020) -
Tumor Immune Microenvironment Characterization of Primary Lung Adenocarcinoma and Lymph Node Metastases
por: Zhou, Yuan, et al.
Publicado: (2021) -
The mutational pattern of homologous recombination-related (HRR) genes in Chinese colon cancer and its relevance to immunotherapy responses
por: Zhou, Pei, et al.
Publicado: (2020) -
Prognostic impact of gene copy number instability and tumor mutation burden in patients with resectable gastric cancer
por: Cai, Lisheng, et al.
Publicado: (2020) -
DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint Inhibitors
por: Song, Yipeng, et al.
Publicado: (2021)